Runben Biotechnology (SH:603193)2025-10-20 10:05Important Disclosures This section provides key statements from the board and management and clarifies the audit status of the financial statements Board of Directors and Management Statement Runben Co., Ltd.'s Board of Directors, senior management, and key financial personnel guarantee the truthfulness, accuracy, and completeness of this quarterly report and assume legal responsibility - The company's Board of Directors and management commit to the truthfulness, accuracy, and completeness of the quarterly report content and assume legal responsibility23 Financial Statement Audit Status The financial statements for this quarter are unaudited - The third-quarter financial statements are unaudited3 I. Major Financial Data This section presents key financial data and indicators for the current quarter and year-to-date, highlighting revenue growth and changes in profitability and cash flow Major Accounting Data and Financial Indicators Runben Co., Ltd.'s key financial data for Q3 2025 and year-to-date shows continued revenue growth, a slight year-over-year decrease in net profit attributable to shareholders for Q3, and a modest increase year-to-date, alongside significant growth in net operating cash flow, total assets, and owner's equity Key Accounting Data and Financial Indicators for Q3 2025 and Year-to-Date | Item | Current Period (2025 Q3) (CNY) | YoY Change (%) | Year-to-Date (2025 YTD) (CNY) | YoY Change (%) | | :--- | :--- | :--- | :--- | :--- | | Operating Revenue | 342,414,289.33 | 16.67 | 1,237,521,845.97 | 19.28 | | Total Profit | 93,417,226.48 | -0.16 | 313,563,619.92 | 3.30 | | Net Profit Attributable to Shareholders | 78,522,780.07 | -2.89 | 266,047,503.56 | 1.98 | | Net Profit Attributable to Shareholders (Excluding Non-Recurring Items) | 74,268,718.88 | -7.58 | 251,228,377.22 | -1.79 | | Net Cash Flow from Operating Activities | 86,714,040.40 | 123.71 | 220,109,889.62 | 22.54 | | Basic Earnings Per Share (CNY/share) | 0.19 | -5.00 | 0.66 | 3.13 | | Diluted Earnings Per Share (CNY/share) | 0.19 | -5.00 | 0.66 | 3.13 | | Weighted Average Return on Net Assets (%) | 3.55 | decreased by 0.35 percentage points | 12.25 | decreased by 0.66 percentage points | Key Balance Sheet Indicators as of Q3 2025 End | Item | As of Current Period End (2025 Q3) (CNY) | As of Prior Year End (2024 FY) (CNY) | Change (%) | | :--- | :--- | :--- | :--- | | Total Assets | 2,306,585,927.30 | 2,219,337,493.41 | 3.93 | | Owner's Equity Attributable to Shareholders | 2,172,526,081.11 | 2,080,453,702.55 | 4.43 | Non-Recurring Gains and Losses Items and Amounts During the reporting period, the company's non-recurring gains and losses primarily stemmed from fair value changes in financial assets, government subsidies, and disposal of non-current assets, collectively having a positive impact on net profit Non-Recurring Gains and Losses Items for Q3 2025 and Year-to-Date | Non-Recurring Gains and Losses Item | Current Period Amount (2025 Q3) (CNY) | Year-to-Date Amount (2025 YTD) (CNY) | | :--- | :--- | :--- | | Gains/Losses from Disposal of Non-Current Assets | - | 80,153.55 | | Government Subsidies Included in Current Profit/Loss | 720,340.74 | 2,178,609.27 | | Gains/Losses from Fair Value Changes and Disposal of Financial Assets and Liabilities | 4,310,292.50 | 15,548,348.99 | | Other Non-Operating Income and Expenses | -49,574.79 | -180,429.35 | | Other Gains/Losses Meeting the Definition of Non-Recurring Items | - | 132,124.78 | | Less: Income Tax Impact | 726,997.26 | 2,939,680.90 | | Total | 4,254,061.19 | 14,819,126.34 | Changes and Reasons for Major Accounting Data and Financial Indicators The company did not disclose the reasons for changes in major accounting data and financial indicators, stating "not applicable" in the report - The company did not provide specific explanations for changes in major accounting data and financial indicators9 II. Shareholder Information This section details the total number of common shareholders and the shareholding structure of the top ten shareholders, including the controlling shareholder and actual controllers Total Number of Common Shareholders and Top Ten Shareholders' Holdings As of the end of the reporting period, the company had 26,173 common shareholders; Guangzhou Zhuofan Investment Holding Co., Ltd. is the controlling shareholder, with actual controllers Zhao Guiqin and Bao Songjuan and their affiliates collectively holding a majority of the company's shares, and several restricted share shareholders are present - As of the end of the reporting period, the total number of common shareholders was 26,173, with no preferred shareholders whose voting rights have been restored10 Top 10 Shareholders' Holdings as of Report Period End | Shareholder Name | Shareholder Nature | Number of Shares Held | Shareholding Ratio (%) | Number of Restricted Shares Held | Pledge, Mark, or Freeze Status | | :--- | :--- | :--- | :--- | :--- | :--- | | Guangzhou Zhuofan Investment Holding Co., Ltd. | Domestic Non-State-Owned Legal Person | 180,387,000 | 44.58 | 180,387,000 | None | | Zhao Guiqin | Domestic Natural Person | 72,522,000 | 17.92 | 72,522,000 | None | | Guangzhou Zhuofan Chengguang Investment Consulting Partnership (Limited Partnership) | Domestic Non-State-Owned Legal Person | 21,420,000 | 5.29 | 21,420,000 | None | | Bao Songjuan | Domestic Natural Person | 19,278,000 | 4.76 | 19,278,000 | None | | JNRY VIII HK Holdings Limited | Overseas Legal Person | 18,644,166 | 4.61 | 0 | None | | Guo Chao | Domestic Natural Person | 5,736,623 | 1.42 | 0 | None | | Zhao Hanqiu | Domestic Natural Person | 4,590,000 | 1.13 | 4,590,000 | None | | Bao Xinzuan | Domestic Natural Person | 3,062,200 | 0.76 | 3,062,200 | None | | Guangzhou Zhuofan Hesheng Investment Holding Partnership (Limited Partnership) | Domestic Non-State-Owned Legal Person | 2,458,300 | 0.61 | 0 | None | | China Life Insurance Co., Ltd. - Traditional - Ordinary Insurance Product - Shanghai 005L - CT001 | Other | 1,463,000 | 0.36 | 0 | None | - Actual controllers Zhao Guiqin and Bao Songjuan are a married couple, collectively controlling a majority of the company's shares through Guangzhou Zhuofan Investment Holding Co., Ltd., Guangzhou Zhuofan Chengguang Investment Consulting Partnership (Limited Partnership), and other affiliated parties11 III. Other Reminders This section addresses any other significant information regarding the company's operating performance during the reporting period that investors should be aware of Other Important Information for Investors Regarding Operating Performance The company did not disclose other important information regarding its operating performance during the reporting period that requires investor attention - The company has no other significant information requiring investor attention12 IV. Quarterly Financial Statements This section presents the unaudited consolidated financial statements, including the balance sheet, income statement, and cash flow statement, for the reporting period Type of Audit Opinion The financial statements for this quarter are unaudited - The financial statements for this quarter are unaudited12 Consolidated Balance Sheet As of September 30, 2025, the company's total assets increased by 3.93% from the prior year-end, primarily driven by significant increases in other current assets and intangible assets, while financial assets held for trading decreased; total liabilities slightly declined, and owner's equity steadily grew Key Consolidated Balance Sheet Item Changes as of September 30, 2025 | Item | September 30, 2025 (CNY) | December 31, 2024 (CNY) | Change Amount (CNY) | Change (%) | | :--- | :--- | :--- | :--- | :--- | | Cash and Cash Equivalents | 109,392,727.45 | 106,589,293.81 | 2,803,433.64 | 2.63 | | Financial Assets Held for Trading | 1,021,497,964.82 | 1,249,074,282.92 | -227,576,318.10 | -18.22 | | Accounts Receivable | 32,243,527.98 | 13,592,744.31 | 18,650,783.67 | 137.21 | | Prepayments | 19,012,284.36 | 11,490,859.76 | 7,521,424.60 | 65.46 | | Inventories | 134,997,615.32 | 118,573,128.58 | 16,424,486.74 | 13.85 | | Other Current Assets | 297,598,019.62 | 90,907,549.62 | 206,690,470.00 | 227.36 | | Total Current Assets | 1,620,157,432.44 | 1,594,831,016.45 | 25,326,415.99 | 1.59 | | Construction in Progress | 50,206,721.26 | 18,071,123.19 | 32,135,598.07 | 177.83 | | Intangible Assets | 87,845,373.26 | 54,538,027.37 | 33,307,345.89 | 61.07 | | Total Non-Current Assets | 686,428,494.86 | 624,506,476.96 | 61,922,017.90 | 9.92 | | Total Assets | 2,306,585,927.30 | 2,219,337,493.41 | 87,248,433.89 | 3.93 | | Accounts Payable | 84,798,947.34 | 61,137,957.35 | 23,660,989.99 | 38.70 | | Contract Liabilities | 2,957,374.81 | 13,365,914.39 | -10,408,539.58 | -77.87 | | Taxes Payable | 25,507,740.76 | 37,825,700.81 | -12,317,960.05 | -32.56 | | Total Current Liabilities | 129,514,452.71 | 137,189,098.79 | -7,674,646.08 | -5.59 | | Deferred Income | 3,959,516.27 | 8,672.57 | 3,950,843.70 | 45555.56 | | Total Non-Current Liabilities | 4,545,393.48 | 1,694,692.07 | 2,850,701.41 | 168.22 | | Total Liabilities | 134,059,846.19 | 138,883,790.86 | -4,823,944.67 | -3.47 | | Total Owner's Equity Attributable to Parent Company | 2,172,526,081.11 | 2,080,453,702.55 | 92,072,378.56 | 4.43 | Consolidated Income Statement In the first three quarters of 2025, the company's total operating revenue increased by 19.28% year-over-year, and net profit grew by 1.98%, with a significant rise in sales expenses, a shift in financial expenses from negative to positive (reduced loss), and a substantial increase in investment income Key Consolidated Income Statement Item Changes for the First Three Quarters of 2025 | Item | First Three Quarters of 2025 (CNY) | First Three Quarters of 2024 (CNY) | Change Amount (CNY) | Change (%) | | :--- | :--- | :--- | :--- | :--- | | Total Operating Revenue | 1,237,521,845.97 | 1,037,514,293.85 | 200,007,552.12 | 19.28 | | Total Operating Costs | 942,106,864.50 | 741,942,471.37 | 200,164,393.13 | 26.98 | | Operating Costs | 516,369,605.76 | 432,283,238.10 | 84,086,367.66 | 19.45 | | Selling Expenses | 370,383,121.28 | 282,898,111.64 | 87,485,009.64 | 30.93 | | Administrative Expenses | 24,465,307.88 | 21,449,066.60 | 3,016,241.28 | 14.06 | | R&D Expenses | 25,135,919.43 | 24,613,948.05 | 521,971.38 | 2.12 | | Financial Expenses | -6,533,683.11 | -30,735,902.67 | 24,202,219.56 | -78.74 | | Investment Income | 15,143,878.85 | 1,032,962.19 | 14,110,916.66 | 1366.12 | | Operating Profit | 313,737,358.02 | 298,569,624.18 | 15,167,733.84 | 5.08 | | Total Profit | 313,563,619.92 | 303,535,006.72 | 10,028,613.20 | 3.30 | | Net Profit | 266,047,503.56 | 260,884,103.81 | 5,163,399.75 | 1.98 | | Basic Earnings Per Share (CNY/share) | 0.66 | 0.64 | 0.02 | 3.13 | Consolidated Cash Flow Statement In the first three quarters of 2025, net cash flow from operating activities significantly increased by 22.54% year-over-year due to higher cash received from sales, while net cash outflow from investing activities substantially decreased, and net cash outflow from financing activities significantly increased, primarily for dividend distribution Key Consolidated Cash Flow Statement Item Changes for the First Three Quarters of 2025 | Item | First Three Quarters of 2025 (CNY) | First Three Quarters of 2024 (CNY) | Change Amount (CNY) | Change (%) | | :--- | :--- | :--- | :--- | :--- | | Cash Received from Sales of Goods and Services | 1,364,507,388.86 | 1,155,002,846.47 | 209,504,542.39 | 18.14 | | Subtotal of Cash Inflows from Operating Activities | 1,373,473,547.02 | 1,164,130,381.55 | 209,343,165.47 | 17.98 | | Cash Paid for Goods and Services | 489,229,188.83 | 530,307,950.22 | -41,078,761.39 | -7.75 | | Cash Paid to and for Employees | 107,286,344.87 | 94,647,705.73 | 12,638,639.14 | 13.35 | | Taxes Paid | 150,552,081.10 | 136,464,958.72 | 14,087,122.38 | 10.32 | | Cash Paid for Other Operating Activities | 406,296,042.60 | 223,084,663.08 | 183,211,379.52 | 82.13 | | Subtotal of Cash Outflows from Operating Activities | 1,153,363,657.40 | 984,505,277.75 | 168,858,379.65 | 17.15 | | Net Cash Flow from Operating Activities | 220,109,889.62 | 179,625,103.80 | 40,484,785.82 | 22.54 | | Cash Received from Disposal of Investments | 1,776,585,834.55 | 631,487,037.81 | 1,145,098,796.74 | 181.33 | | Cash Received from Investment Income | 16,514,281.63 | 21,032,810.98 | -4,518,529.35 | -21.48 | | Cash Paid for Investments | 1,761,605,046.31 | 866,404,493.19 | 895,200,553.12 | 103.32 | | Net Cash Flow from Investing Activities | -42,162,777.55 | -259,172,089.84 | 217,009,312.29 | -83.73 | | Cash Paid for Dividends, Profit Distribution, or Interest Payments | 173,981,525.60 | 68,780,863.38 | 105,200,662.22 | 152.95 | | Net Cash Flow from Financing Activities | -175,120,824.80 | -74,871,162.58 | -100,249,662.22 | 133.89 | | Net Increase in Cash and Cash Equivalents | 2,803,433.64 | -154,418,460.86 | 157,221,894.50 | -101.82 | | Cash and Cash Equivalents at Period End | 109,392,727.45 | 129,406,720.91 | -20,013,993.46 | -15.47 |